$AVNR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AVANIR PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in AVANIR PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AVANIR PHARMACEUTICALS, INC. for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 22 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseM2.5932,29183,6340
Dec 22 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DSellS16.9315,505262,500314,192329.7 K to 314.2 K (-4.70 %)
Dec 22 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DPayment of ExerciseF16.9919,204326,276329,697348.9 K to 329.7 K (-5.50 %)
Dec 22 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DBuyM2.5932,29183,634348,901316.6 K to 348.9 K (+10.20 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM4.1817,50073,1500
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM2.5912,50032,37517,500
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS16.935,78097,855108,797114.6 K to 108.8 K (-5.04 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS16.9417,500296,450114,577132.1 K to 114.6 K (-13.25 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS16.9412,500211,750132,077144.6 K to 132.1 K (-8.65 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM4.1817,50073,150144,577127.1 K to 144.6 K (+13.77 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM2.5912,50032,375127,077114.6 K to 127.1 K (+10.91 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM1.74139,200242,208976,769
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM1.2955,96072,188976,769
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS16.9362,5201,058,464914,249976.8 K to 914.2 K (-6.40 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS16.95195,1603,307,962976,7691.2 M to 976.8 K (-16.65 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM1.2955,96072,1881,171,9291.1 M to 1.2 M (+5.01 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM1.74139,200242,2081,115,969976.8 K to 1.1 M (+14.25 %)
Dec 18 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS16.9520,000339,000976,769996.8 K to 976.8 K (-2.01 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0034,8250317,806283 K to 317.8 K (+12.31 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0059,2310282,981223.8 K to 283 K (+26.47 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0034,8250316,610281.8 K to 316.6 K (+12.36 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0059,2310281,785222.6 K to 281.8 K (+26.61 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.00140,6110996,769856.2 K to 996.8 K (+16.42 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.00220,5630856,158635.6 K to 856.2 K (+34.70 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0019,8440114,57794.7 K to 114.6 K (+20.95 %)
Nov 12 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0031,992094,73362.7 K to 94.7 K (+50.99 %)
Oct 24 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DSellS11.808,42699,427222,554231 K to 222.6 K (-3.65 %)
Oct 24 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS11.7627,567324,188732,845760.4 K to 732.8 K (-3.63 %)
Oct 24 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS11.812,08024,56577,79179.9 K to 77.8 K (-2.60 %)
Sep 17 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM4.1855,000229,90017,500
Sep 17 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS9.4555,000519,75079,871134.9 K to 79.9 K (-40.78 %)
Sep 17 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...Option ExerciseM3.3825,00084,500250,000
Sep 17 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...SellS12.5015,000187,500266,750281.8 K to 266.8 K (-5.32 %)
Sep 17 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...SellS10.0010,000100,000266,750276.8 K to 266.8 K (-3.61 %)
Aug 28 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS6.102,11012,87179,87182 K to 79.9 K (-2.57 %)
Aug 01 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS5.269,67050,864760,412770.1 K to 760.4 K (-1.26 %)
Jul 10 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.0020,0000770,082750.1 K to 770.1 K (+2.67 %)
May 30 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.88317,212279,1470
May 30 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM1.2975,00096,75055,960
May 30 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS5.01442,2122,215,482750,0821.2 M to 750.1 K (-37.09 %)
May 30 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseM1.8510,54719,51224,609
May 30 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DSellS5.1813,54770,173230,980244.5 K to 231 K (-5.54 %)
May 22 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseD2.8426,25074,550125,000
May 16 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS4.8811,90058,0723,00014.9 K to 3 K (-79.87 %)
May 16 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS5.1325,596131,30781,981107.6 K to 82 K (-23.79 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Podlesak DennisDirectorGrantA0.0028,9000336,394307.5 K to 336.4 K (+9.40 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...WHEELER CRAIG ADirectorGrantA0.0028,9000400,394371.5 K to 400.4 K (+7.78 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Nevinny Corinne HDirectorGrantA0.0021,700080,05058.4 K to 80.1 K (+37.19 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Mazzo David JDirectorGrantA0.0028,9000336,394307.5 K to 336.4 K (+9.40 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Bishop Hans EdgarDirectorGrantA0.0028,900093,35064.5 K to 93.4 K (+44.84 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0015,0500107,57792.5 K to 107.6 K (+16.27 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0029,325092,52763.2 K to 92.5 K (+46.40 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0043,0000266,750223.8 K to 266.8 K (+19.22 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0080,7500223,750143 K to 223.8 K (+56.47 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0043,0000233,980191 K to 234 K (+22.52 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0080,7500190,980110.2 K to 191 K (+73.26 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.0097,2500800,082702.8 K to 800.1 K (+13.84 %)
Feb 14 2014AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.00257,1250702,832445.7 K to 702.8 K (+57.69 %)
Dec 20 2013AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DSellS2.635,97015,713110,230116.2 K to 110.2 K (-5.14 %)
Dec 20 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS2.632,4506,44563,20265.7 K to 63.2 K (-3.73 %)
Dec 20 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS2.6729,51578,935445,707475.2 K to 445.7 K (-6.21 %)
Dec 19 2013AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...BuyP2.8010,00028,000143,000133 K to 143 K (+7.52 %)
Dec 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseA2.84151,250429,550151,250
Dec 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseA2.8417,25048,99017,250
Dec 17 2013AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...Option ExerciseA2.8447,500134,90047,500
Dec 17 2013AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseA2.8447,500134,90047,500
Nov 05 2013AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...BuyP4.1910,00041,895133,000123 K to 133 K (+8.13 %)
Nov 05 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS4.144,38518,138475,222479.6 K to 475.2 K (-0.91 %)
Sep 19 2013AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseM1.8521,09439,02435,156
Sep 19 2013AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DSellS4.2221,09488,968116,200137.3 K to 116.2 K (-15.36 %)
Sep 19 2013AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DBuyM1.8521,09439,024137,294116.2 K to 137.3 K (+18.15 %)
Aug 02 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS4.8415,50074,981479,607495.1 K to 479.6 K (-3.13 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.88159,638140,48153,212
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.5355,80029,5740
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS3.26215,438702,220495,107710.5 K to 495.1 K (-30.32 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM0.88159,638140,481710,545550.9 K to 710.5 K (+28.98 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM0.5355,80029,574550,907495.1 K to 550.9 K (+11.27 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS3.2635,000114,093495,107530.1 K to 495.1 K (-6.60 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.8838,70034,0560
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.8815,00013,2000
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.884,0003,5200
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS3.2857,700189,41865,652123.4 K to 65.7 K (-46.78 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.8838,70034,056123,35284.7 K to 123.4 K (+45.72 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.8815,00013,20084,65269.7 K to 84.7 K (+21.54 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.884,0003,52069,65265.7 K to 69.7 K (+6.09 %)
May 17 2013AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS3.2920,00065,83265,65285.7 K to 65.7 K (-23.35 %)
Mar 12 2013AVNRAVANIR PHARMACEUTI ...Nevinny Corinne HDirectorGrantA0.0058,350058,3500 to 58.4 K
Feb 19 2013AVNRAVANIR PHARMACEUTI ...Mazzo David JDirectorGrantA0.0038,9000307,494268.6 K to 307.5 K (+14.48 %)
Feb 19 2013AVNRAVANIR PHARMACEUTI ...Whitcup Scott MDirectorGrantA0.0038,9000306,494267.6 K to 306.5 K (+14.54 %)
Feb 19 2013AVNRAVANIR PHARMACEUTI ...WHEELER CRAIG ADirectorGrantA0.0038,9000371,494332.6 K to 371.5 K (+11.70 %)
Feb 19 2013AVNRAVANIR PHARMACEUTI ...Podlesak DennisDirectorGrantA0.0038,9000307,494268.6 K to 307.5 K (+14.48 %)
Feb 19 2013AVNRAVANIR PHARMACEUTI ...Bishop Hans EdgarDirectorGrantA0.0019,450064,45045 K to 64.5 K (+43.22 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseA2.5932,50084,17532,500
Dec 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.008,963085,65276.7 K to 85.7 K (+11.69 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0021,288076,68955.4 K to 76.7 K (+38.43 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...Option ExerciseA2.5956,250145,68856,250
Dec 19 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0026,1560123,00096.8 K to 123 K (+27.01 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0036,844096,84460 K to 96.8 K (+61.41 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseA2.5975,000194,25075,000
Dec 19 2012AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0034,8750116,20081.3 K to 116.2 K (+42.88 %)
Dec 19 2012AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0049,125081,32532.2 K to 81.3 K (+152.56 %)
Dec 17 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...BuyP2.4610,00024,59860,00050 K to 60 K (+20.00 %)
Dec 05 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS2.552,8457,25855,40158.2 K to 55.4 K (-4.88 %)
Dec 05 2012AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS2.5518,25046,457119,482137.7 K to 119.5 K (-13.25 %)
Nov 02 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...Option ExerciseA3.38275,000929,500275,000
Nov 02 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0030,000050,00020 K to 50 K (+150.00 %)
Nov 02 2012AVNRAVANIR PHARMACEUTI ...PALEKAR ROHANSVP & Chief Commerc ...GrantA0.0020,000020,0000 to 20 K
Sep 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.5365,00034,45065,000
Sep 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS3.4965,000226,82458,246123.2 K to 58.2 K (-52.74 %)
Sep 19 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.5365,00034,450123,24658.2 K to 123.2 K (+111.60 %)
Jun 27 2012AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS3.50190,125664,791137,732327.9 K to 137.7 K (-57.99 %)
May 25 2012AVNRAVANIR PHARMACEUTI ...Bishop Hans EdgarDirectorGrantA0.0045,000045,0000 to 45 K
May 14 2012AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DBuyP2.962,7007,99232,20029.5 K to 32.2 K (+9.15 %)
Mar 07 2012AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyP2.603,0007,7953,0000 to 3 K
Mar 07 2012AVNRAVANIR PHARMACEUTI ...MATHEWS CHARLESDirectorBuyP2.695,00013,4735,0000 to 5 K
Mar 07 2012AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyP2.6110,00026,093327,857317.9 K to 327.9 K (+3.15 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...Mazzo David JDirectorGrantA0.0030,0000268,594238.6 K to 268.6 K (+12.57 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...MATHEWS CHARLESDirectorGrantA0.0030,0000270,094240.1 K to 270.1 K (+12.50 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...Whitcup Scott MDirectorGrantA0.0030,0000267,594237.6 K to 267.6 K (+12.63 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...WHEELER CRAIG ADirectorGrantA0.0030,0000327,594297.6 K to 327.6 K (+10.08 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...AUSTIN STEPHEN GDirectorGrantA0.0030,0000270,094240.1 K to 270.1 K (+12.50 %)
Feb 17 2012AVNRAVANIR PHARMACEUTI ...Podlesak DennisDirectorGrantA0.0030,0000268,594238.6 K to 268.6 K (+12.57 %)
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DOption ExerciseA1.8556,250104,06356,250
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.0021,375029,5008.1 K to 29.5 K (+263.08 %)
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Siffert Joao MDSVP, R&DGrantA0.008,12508,1250 to 8.1 K
Dec 16 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseA1.8590,000166,50090,000
Dec 16 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.0013,750058,24644.5 K to 58.2 K (+30.90 %)
Dec 16 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...GrantA0.006,250044,49638.2 K to 44.5 K (+16.34 %)
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseA1.85337,500624,375337,500
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.0097,0000317,857220.9 K to 317.9 K (+43.92 %)
Dec 16 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOGrantA0.0030,0000220,857190.9 K to 220.9 K (+15.72 %)
Dec 06 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS2.3717,49541,421190,857208.4 K to 190.9 K (-8.40 %)
Dec 06 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS2.382,6766,37238,24640.9 K to 38.2 K (-6.54 %)
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.88106,42593,654319,275
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.532,5871,371139,500
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOOption ExerciseM0.53109,01357,777142,087
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS2.59109,012282,657208,352317.4 K to 208.4 K (-34.35 %)
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM0.88106,42593,654317,364210.9 K to 317.4 K (+50.45 %)
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM0.532,5871,371210,939208.4 K to 210.9 K (+1.24 %)
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOSellS2.59109,013282,300208,352317.4 K to 208.4 K (-34.35 %)
Nov 18 2011AVNRAVANIR PHARMACEUTI ...Katkin KeithPresident and CEOBuyM0.53109,01357,777317,365208.4 K to 317.4 K (+52.32 %)
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.8864,50056,76038,700
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.8812,00010,56015,000
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM0.8812,00010,5604,000
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...Option ExerciseM1.203,7504,5000
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...SellS2.6292,250242,05540,922133.2 K to 40.9 K (-69.27 %)
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.8864,50056,760133,17268.7 K to 133.2 K (+93.92 %)
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.8812,00010,56068,67256.7 K to 68.7 K (+21.17 %)
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM0.8812,00010,56056,67244.7 K to 56.7 K (+26.86 %)
Nov 14 2011AVNRAVANIR PHARMACEUTI ...OCAMPO CHRISTINEVice President, Fin ...BuyM1.203,7504,50044,67240.9 K to 44.7 K (+9.16 %)

Page:   1 2 3 4 4 next >

Contact us | Follow us on Twitter